Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[EHBMP-2. Initial BMP analog with osteoinductive properties].

N R Kübler¹, K Würzler, J F Reuther

¹Klinik und Poliklinik für Mund-, Kiefer-, Gesichtschirurgie, Bayerische Julius-Maximilians-Universität Würzburg.

Mund-, Kiefer- Und Gesichtschirurgie : MKG

|July 22, 1999

Summary

A novel engineered BMP-2 variant (EHBMP-2) shows potent osteoinductive properties, promoting bone formation in vivo. This engineered protein holds promise for bone regeneration and tissue engineering applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

LIN28 promotes tumorigenesis in colorectal cancer but is not associated with metastatic spread.

Pathology, research and practice·2021

Same author

Retraction notice to "The association between metformin therapy and risk of gynecological cancer in patients: two meta-analyses" [British Journal of Oral and Maxillofacial Surgery, Volume 57, Issue 8, October 2019, Pages 782-787].

The British journal of oral & maxillofacial surgery·2021

Same author

Biomarker alterations associated with distinct patterns of metastatic spread in colorectal cancer.

Virchows Archiv : an international journal of pathology·2020

Same author

[A 3-week history of intestinal symptoms in a 67-year-old male patient with chronic arthralgia].

Der Internist·2020

Same author

Correction to: The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence.

World journal of urology·2020

Same author

Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2019

Area of Science:

Biotechnology
Molecular Biology
Regenerative Medicine

Context:

Bone morphogenetic proteins (BMPs) are crucial for bone formation.
Developing novel BMP variants can enhance therapeutic potential.
Understanding BMP-2's interaction with the extracellular matrix is key.

Purpose:

To engineer a novel BMP-2 variant (EHBMP-2) with enhanced osteoinductive properties.
To investigate the in vitro and in vivo effects of EHBMP-2 on bone and cartilage formation.
To evaluate EHBMP-2's efficacy in bone defect repair.

Summary:

Engineered BMP-2 variant (EHBMP-2) produced in E. coli exhibits significant osteoinductive capacity.
EHBMP-2 induces dose-dependent cartilage formation in vitro and bone formation (ossicles) in vivo.

Related Experiment Videos

Combination with collagen carriers enhances EHBMP-2's bone-forming potential, outperforming natural BMP-2 in some applications.

EHBMP-2 successfully restored critical-sized mandibular defects in rats when combined with ICBM.

Impact:

EHBMP-2 demonstrates potential as a therapeutic agent for bone regeneration.
The engineered variant shows promise for advancing tissue engineering strategies.
Further research into EHBMP-2's pharmacokinetics may reveal therapeutic advantages.